Roderick Clifton-Bligh
Royal North Shore Hospital, NSW, Australia
- This delegate is presenting an abstract at this event.
Prof Roderick Clifton-Bligh is Head of the Department of Endocrinology at Royal North Shore Hospital, and conjoint professor in Medicine at the University of Sydney. He has been a clinician researcher since completing a PhD in the genetics of thyroid disorders at the University of Cambridge in 1998. His research focuses on the molecular bases of endocrine neoplasms, including Multiple Endocrine Neoplasia syndromes, thyroid cancer, phaeochromocytoma/paraganglioma syndromes, adrenal cancer, and pituitary neoplasms. He is passionate about teaching and mentoring young physicians and has supervised 14 completed PhDs with six in progress. His work has been recognized by awards from NSW Cancer Institute (2013), Asia-Oceania Thyroid Association (2014) and the Endocrine Society of Australia Outstanding Clinical Practitioner Award (2021).
Presentations this author is a contributor to:
Circulating GDF-15 as a Biomarker of Activity in Oncocytic Thyroid Cancer (#106)
1:30 PM
Stephen Ludgate
ESA Clinical Orals and Lightning Talks
Expanding the CASR variant landscape: integrated in silico and structural triage of previously unreported germline variants (#172)
12:00 PM
Sarah C Brennan
CaSR-5 Session-4: Oral Posters
Serum thyroglobulin by mass spectrometry versus immunoassay in thyroid cancer patients with anti-thyroglobulin antibodies: an interim analysis (#301)
5:30 PM
Sarah C Brennan
Joint Poster Session
Catecholamine burden and germline genotype independently predict cardiovascular phenotype in phaeochromocytoma and paraganglioma (#341)
5:30 PM
Matti L Gild
Joint Poster Session